KR900002055B1 - Pyrazole derivatives having pysiological activity and the preparing method thereof - Google Patents
Pyrazole derivatives having pysiological activity and the preparing method thereof Download PDFInfo
- Publication number
- KR900002055B1 KR900002055B1 KR1019870011155A KR870011155A KR900002055B1 KR 900002055 B1 KR900002055 B1 KR 900002055B1 KR 1019870011155 A KR1019870011155 A KR 1019870011155A KR 870011155 A KR870011155 A KR 870011155A KR 900002055 B1 KR900002055 B1 KR 900002055B1
- Authority
- KR
- South Korea
- Prior art keywords
- general formula
- group
- compound
- compound represented
- lower alkyl
- Prior art date
Links
- 0 CC1C(COP(*)(*)=*)N*C1 Chemical compound CC1C(COP(*)(*)=*)N*C1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
본 발명은 살충제로 유용한 신규의 다음 일반식(I)의 피라졸 유도체 및 그 제조방법에 관한 것이다.The present invention relates to novel pyrazole derivatives of the general formula (I) which are useful as insecticides and methods for their preparation.
식중, R1은 일반식아릴설폰기, 일반식의 아릴 설파이드기, 일반식의 알킬설폰기, R5-S-의 알킬 설파이드기, 일반식의 알콕시 카르보닐기, 일반식의 디알킬 포스포노기, R2는 수소, 저급알킬기, 할로겐원자 혹은 니트로 치환기 혹은 저급알칼리로 치환되어 있어도 되는 페닐기, R3는 저급알킬기, R4는 일반식 -OR8의 알콕시기, 하나 또는 그 이상의 할로겐 또는 니트로 치환기를 임의로 갖는 페녹시기 및 티오페녹시기, 저급알킬티오기, R5, R6, R7및 R8는 저급알킬기, X는 산소원자 또는 유황원자.Wherein R 1 is a general formula Aryl sulfone group, general formula Aryl sulfide group, general formula Alkyl sulfone group, R 5 -S- alkyl sulfide group, general formula Alkoxy carbonyl group, general formula A dialkyl phosphono group, R 2 is hydrogen, a lower alkyl group, a halogen atom or a phenyl group which may be substituted with a nitro substituent or a lower alkali, R 3 is a lower alkyl group, R 4 is an alkoxy group of the formula -OR 8 , or Phenoxy and thiophenoxy groups, lower alkylthio groups, R 5 , R 6 , R 7 and R 8 are lower alkyl groups, X is an oxygen atom or a sulfur atom, optionally having more halogen or nitro substituents.
한국 특허공고 제84-255호에는 피라졸계 인산에스테르에 대하여 기술하고 있다.Korean Patent Publication No. 84-255 describes pyrazole type phosphate esters.
그러나 상기 문헌에는 본 발명의 화합물에 관하여는 언급하고 있지 않다.However, this document does not mention the compounds of the present invention.
따라서 본 발명의 목적은 신규의 생리활성을 가지는 피라졸 유도체를 제공하는 것이다.It is therefore an object of the present invention to provide pyrazole derivatives having novel physiological activity.
본 발명의 또 다른 목적은 신규의 생리활성을 가지는 피라졸 유도체의 제조방법을 제공하는 것이다.Still another object of the present invention is to provide a method for preparing a pyrazole derivative having a novel physiological activity.
일반식(1)중, R1으로 표시되는 치환페닐기중의 할로겐원자 및 R2, R4에 표시되는 할로겐 원자는 풀루오르원자, 염소원자 또는 브롬원자이다. R2, R3, R5, R6, R7, R8로 표시되는 저급알킬기로서는 탄소수 1-4의 직쇄상, 분지쇄상의 알킬기를 뜻하며, 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸기 등을 들 수 있다. 그중에서도 특히 좋은 것은 메틸 또는 에틸기이다. R4가 알콕시기를 나타내는 경우, 1 내지 4개의 탄소원자를 갖는 직쇄 또는 분지쇄 알콕시기(예를 들면, 메톡시, 에톡시, 프로폭시, 이소프로폭시, 부톡시, 이소부톡시, sec-부톡시, t-부톡시기)가 적당하지만 특히 메톡시 또는 에톡시기가 더 바람직하다. R4가 표시되는 저급알킬티오기로서는 메틸티오, 에틸티오, n-프로필티오, 이소프로필티오, n-부틸티오, 이소부틸티오, sec-부틸티오기 등을 들수 있으며, 그중에서도 특히 n-프로필티오기가 바람직하다.In the general formula (1), the halogen atom in the substituted phenyl group represented by R 1 and the halogen atom represented by R 2 and R 4 are a pullor atom, a chlorine atom or a bromine atom. The lower alkyl group represented by R 2 , R 3 , R 5 , R 6 , R 7 , or R 8 means a linear or branched alkyl group having 1 to 4 carbon atoms, which is methyl, ethyl, n-propyl, isopropyl, n -Butyl, isobutyl, sec-butyl group, etc. are mentioned. Especially good among them are methyl or ethyl groups. When R 4 represents an alkoxy group, a straight or branched chain alkoxy group having 1 to 4 carbon atoms (for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, t-butoxy group) is suitable, but more particularly methoxy or ethoxy group. Examples of the lower alkylthio group represented by R 4 include methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio group and the like, and in particular, n-propylthio. Group is preferred.
본 발명의 화합물을 좀더 특징지어 기술하면,When the compound of the present invention is further characterized and described,
첫째 : R1이 (R7O)2P-, R7이 메틸기 또는 에틸기, R2가 메틸기, R3가 메틸기 또는 에틸기, R4가 알콕시기, 알킬티오기, 티오페녹시기, O-클로로 페녹시기, X가 산소 또는 유황원자를 뜻하는 일반식(1)의 화합물을 들수 있다.First: R 1 is (R 7 O) 2 P-, R 7 is methyl or ethyl, R 2 is methyl, R 3 is methyl or ethyl, R 4 is alkoxy, alkylthio, thiophenoxy, O- The chloro phenoxy group and the compound of General formula (1) which X represents oxygen or a sulfur atom are mentioned.
둘째 : R1이 아릴설폰기, R2가 메틸기, R3가 메틸기 또는 에틸기, R2가 알콕시기, 알킬티오기, 티오페녹시기, O-클로로페녹시기, X가 산소 또는 유황원자인 일반식(1)의 화합물.Second: general in which R 1 is an aryl sulfone group, R 2 is methyl group, R 3 is methyl group or ethyl group, R 2 is alkoxy group, alkylthio group, thiophenoxy group, O-chlorophenoxy group, X is oxygen or sulfur atom Compound of formula (1).
셋째 : R1이 알킬티오기, R2가 메틸기, R3가 메틸기 또는 에틸기, R4가 알콕시기, 알킬티오기, 티오페녹시기, O-클로로페녹시기, X가 산소 또는 유황원자를 뜻하는 일반식(1)의 화합물.Third: R 1 is alkylthio group, R 2 is methyl group, R 3 is methyl group or ethyl group, R 4 is alkoxy group, alkylthio group, thiophenoxy group, O-chlorophenoxy group, X is oxygen or sulfur atom Compound of general formula (1).
넷째 : R1이 알콕시 카르보닐기, R2가 메틸기, R3가 메틸기 또는 에틸기, R4가 알콕시기, 알킬티오기, 티오페녹시기, O-클로로페녹시기, X가 산소 또는 유황원자를 뜻하는 일반식(1)의 화합물을 들수 있다.Fourth: R 1 is an alkoxycarbonyl group, R 2 is a methyl group, R 3 is a methyl group or an ethyl group, R 4 is an alkoxy group, an alkylthio group, thiophenoxy group, O-chlorophenoxy group, X is an oxygen or sulfur atom The compound of General formula (1) is mentioned.
본 발명에 따른 화합물의 특별한 예를 표 1에 기재한 것들이다.Specific examples of the compounds according to the invention are those listed in Table 1.
[표 1a]TABLE 1a
[표 1b]TABLE 1b
[표 1c]TABLE 1c
[표 1d]TABLE 1d
[표 1e]TABLE 1e
[표 1f]TABLE 1f
[표 1g]Table 1g
[표 1h]Table 1h
[표 1i]TABLE 1i
본 발명의 화합물은 신규 화합물인 피라졸(2)로부터 간편하게 제조할 수 있다. 예를 들면 일반식(2)The compound of the present invention can be conveniently prepared from pyrazole (2), which is a novel compound. For example, general formula (2)
(식중, R1, R2는 상술한 바와간다.)로 표시되는 화합물 또는 그 염을 일반식(3)Wherein R 1 and R 2 are the same as described above. The compound represented by General Formula (3)
(식중, Hal은 할로겐 원자를 나타내며, R3, R4는 상술한 바와 같다)로 표시되는 화합물로 에스테르화 시킴으로서 제조할 수 있다. 에스테르화의 반응은 산결합제의 존재하에서 행하는 것이 바람직하다. 적당한 산결합제로서는 제3급 아민류 혹은 알칼리금속 및 알칼리토류 금속의 수산화물, 산화물, 탄산염, 중탄산염, 및 알칼리금속 알코올 레이트류가 사용된다.In the formula, Hal represents a halogen atom, and R 3 and R 4 are the same as those described above. It is preferable to perform reaction of esterification in presence of an acid binder. Suitable acid binders include tertiary amines or hydroxides, oxides, carbonates, bicarbonates, and alkali metal alcoholates of alkali and alkaline earth metals.
일반식(2)의 3-히드록시 피라졸 화합물의 염은 대응하는 알칼리 금속 염이 적당하며, 나트륨염, 칼륨염등이 바람직하다. 반응은 일반적으로 적당한 불활성용매 중에서 행하여지는 것이 바람직하다. 반응온도는 -20∼150℃의 범위에서 반응이 진행하는 온도를 선택할 수 있으나, 일반적으로 0°-100℃가 적당한 것이다. 반응은 1시간-6시간에서 완결되며, 그 종료는 박층 크로마토그래피 등에 의해서 확인할 수 있다. 반응 종료후, 반응 혼합물로부터 여러가지 수단에 의해서 목적물을 취득할 수 있다. 예를 들면, 반응액을 여과한 후 용매를 제거하여 본 발명 화합물을 얻는다. 소망에 따라 다시증류, 재결정, 칼럼 크로마토그래피 등의 수단으로 다시 정제하여도 된다.As the salt of the 3-hydroxypyrazole compound of the general formula (2), a corresponding alkali metal salt is suitable, and sodium salt, potassium salt and the like are preferable. It is preferable that reaction is generally performed in a suitable inert solvent. The reaction temperature may be selected from -20 to 150 ℃ the temperature at which the reaction proceeds, generally 0 ° -100 ℃. The reaction is completed in 1 hour-6 hours, and the end can be confirmed by thin layer chromatography or the like. After completion of the reaction, the target product can be obtained from the reaction mixture by various means. For example, the reaction solution is filtered and then the solvent is removed to obtain the compound of the present invention. If desired, it may be purified again by means such as distillation, recrystallization, column chromatography, or the like.
상기한 방법에 의해 본 발명 화합물을 제조할 때 사용되는 피라졸(2)는 신규 화합물로서 이것은 다음과 같이하여 제조할 수 있다.The pyrazole (2) used when producing the compound of the present invention by the above method is a novel compound, which can be produced as follows.
상기식에서, R1, R2는 상술한 바와 같고, R9는 저급알킬기이다.Wherein R 1 , R 2 are as defined above and R 9 is a lower alkyl group.
본 발명의 또다른 목적은 출발물질로 사용되는 신규의 구조식 (2) 화합물의 제조방법을 제공하는 것이다.It is another object of the present invention to provide a process for the preparation of the novel compound of formula (2) for use as a starting material.
화합물(4)로부터 화합물(5)를 만드는 반응은 적당한 불활성 용매 중에서 행하여질 수 있고, 용매를 사용하지 않고 수행할 수도 있다. 반응온도는 -20°-50℃의 범위에서 반응이 진행하는 온도를 선택할 수 있으나, 일반적으로 0°-100℃가 적당하다. 반응시간은 0.5-8시간에서 완결된다. 화합물(5)를 치환된 히드라진과 반응시켜 목적하는 피라졸(2)를 얻는 반응은 적당한 용매의 존재하에 진행시키는 것이 좋으며, 특히 에탄올이 바람직하다. 반응온도는 한정된 것이 아니지만 편의상 -20℃부터 용매의 환류온도 사이의 온도범위내에서 반응시킨다. 반응시간은 2시간-8시간에서 완결된다. 반응이 완결되면, 여러가지 방법으로 목적하는 화합물을 반응혼합물로부터 분리하고 필요에 따라서는 증류, 재결정 또는 크로마토그래피와 같은 통상적인 방법으로 정제한다.The reaction for making compound (5) from compound (4) can be carried out in a suitable inert solvent or can be carried out without using a solvent. The reaction temperature can be selected from the temperature of the reaction proceeds in the range of -20 ° -50 ℃, 0 ° -100 ℃ is generally suitable. The reaction time is completed at 0.5-8 hours. The reaction for obtaining the desired pyrazole (2) by reacting the compound (5) with a substituted hydrazine is preferably carried out in the presence of a suitable solvent, particularly preferably ethanol. The reaction temperature is not limited but, for convenience, is reacted within a temperature range between -20 ° C and the reflux temperature of the solvent. The reaction time is completed at 2-8 hours. Upon completion of the reaction, the desired compound is separated from the reaction mixture in various ways and, if necessary, purified by conventional methods such as distillation, recrystallization or chromatography.
본 발명에 따른 피라졸(2)의 특별한 예는 표 2에 기재한 것들이다.Particular examples of pyrazole (2) according to the invention are those listed in Table 2.
[표 2]TABLE 2
본 발명 화합물(1)은 위생해충, 식물기생곤충, 진드기류 및 응애에 대해 뛰어난 방제효과를 나타낸다. 대표적으로 선택된 몇개의 화합물에 대한 살충 및 살비활성의 시험은 실험예 15에 상술되어 있다.Compound (1) of the present invention exhibits excellent control effects against hygienic pests, plant parasitic insects, mites and mites. Test of pesticidal and acaricide activity for several representatively selected compounds is detailed in Experimental Example 15.
다음의 실시예에 의해서 본 발명을 상세히 설명하는데, 본 발명은 이들의 실시예에 한정시키는 것은 아니다.The present invention will be described in detail by the following examples, but the present invention is not limited to these examples.
[실시예 1]Example 1
3-히드록시-1-메틸-4-페닐설폰일 피라졸(화합물번호 170):3-hydroxy-1-methyl-4-phenylsulfonyl pyrazole (Compound No. 170):
에탄올중에 1g(3.7미리몰)의 1-메톡시카르보닐-1-페닐설폰일-2-(N, N-디메틸아미노)에텐을 넣고 0℃로 냉각시킨다.1 g (3.7 mmol) of 1-methoxycarbonyl-1-phenylsulfonyl-2- (N, N-dimethylamino) ethene is added to ethanol and cooled to 0 ° C.
여기서 메틸 히드라진(0.24ml, 4.4미리몰)을 적가한다.Methyl hydrazine (0.24 ml, 4.4 mmol) is added dropwise here.
반응혼합물 0℃에서 1시간, 실온에서 4시간, 환류하에 4시간 교반한다. 반응 종료후, 진공하에 용매를 제거한 후, 진공 증류를 하여 붉은색의 액체를 얻었다. 이것을 에탄올로부터 재결정하여 0.63g의 피라졸을 고체로 얻었다. 융점:193-194℃.The reaction mixture is stirred at 0 ° C. for 1 hour, at room temperature for 4 hours, and under reflux for 4 hours. After the completion of the reaction, the solvent was removed under vacuum, and then vacuum distilled to obtain a red liquid. This was recrystallized from ethanol to give 0.63 g of pyrazole as a solid. Melting point: 193-194 ° C.
1H NMR(DMSO-d6) : 3.7(s, 3H), 7.2-7.85(m, 6H), 9.8(s, 1H). 1 H NMR (DMSO-d 6 ): 3.7 (s, 3H), 7.2-7.85 (m, 6H), 9.8 (s, 1H).
MS(70eV) 238(M+).MS (70 eV) 238 (M < + & gt ; ).
상기한 바와 같은 방법으로, 메틸 히드라진대신 히드라진, 페닐히드라진을 사용하여 화합물번호 169, 171을 얻었다In the same manner as described above, Compound Nos. 169 and 171 were obtained using hydrazine and phenylhydrazine instead of methyl hydrazine.
[실시예 2]Example 2
3-히드록시-1-메틸-4-페닐티오피라졸(화합물번호 173) :3-hydroxy-1-methyl-4-phenylthiopyrazole (Compound No. 173):
에탄올중에 1g(4.2미리몰)의 1-메톡시카르보닐-1-페닐티오-2-(N, N-디메틸아미노)에텐을 넣고 0℃로 냉가기킨다. 여기에 메틸히드라진(0.27ml, 5.0미리몰)을 적가한다. 반응혼합물을 0℃에서 1시간, 실온에서 2시간, 환류하에 5시간 교반한다. 반응 종료후, 진공하에 용매를 제거한 후 에탄올로 부터 재결정하여 0.65g의 피라졸을 얻었다.1 g (4.2 mmol) of 1-methoxycarbonyl-1-phenylthio-2- (N, N-dimethylamino) ethene is added to ethanol and cooled to 0 ° C. To this was added methylhydrazine (0.27 ml, 5.0 mmol) dropwise. The reaction mixture is stirred at 0 ° C. for 1 hour, at room temperature for 2 hours and under reflux for 5 hours. After the completion of the reaction, the solvent was removed in vacuo and then recrystallized from ethanol to obtain 0.65 g of pyrazole.
1H NMR(DMSO-d6) : 3.65(s, 1H), 7.1-7.55(m, 6H), 9.5(s, 1H). 1 H NMR (DMSO-d 6 ): 3.65 (s, 1H), 7.1-7.55 (m, 6H), 9.5 (s, 1H).
MS(70eV) 206(M+).MS (70 eV) 206 (M < + & gt ; ).
상기한 바와 같은 방법으로 메틸히드라진 대신 히드라진, 페닐히드라진을 사용하여 화합물번호 172, 174를 제조하였다.Compound Nos. 172 and 174 were prepared using hydrazine and phenylhydrazine instead of methylhydrazine in the same manner as described above.
[실시예 3]Example 3
3-히드록시-1-메틸-4-메틸설폰일 피라졸(화합물번호 176) :3-hydroxy-1-methyl-4-methylsulfonyl pyrazole (Compound No. 176):
1-에톡시카르보닐-1-메틸설폰일-2-(N, N-디메틸아미노)에텐(1g, 4.5미리몰)을 에탄올에 넣고 0℃로 냉각시킨다. 여기에 메틸히드라진(0.26ml, 4.9미리몰)을 적가한다. 반응혼합물을 0℃에서 1시간, 실온에서 2시간, 환류하에 4시간 교반한다. 반응 종료후 진공하에 용매를 제거한 후 실리카겔 상에서 메탄올과 에틸아세테이트(1:4)의 혼합물로 칼럼 크로마토그래피한 결과, 목적하는 화합물이 고체(0.55g)로서 얻어졌다.1-Ethoxycarbonyl-1-methylsulfonyl-2- (N, N-dimethylamino) ethene (1 g, 4.5 mmol) was added to ethanol and cooled to 0 ° C. To this was added methylhydrazine (0.26 ml, 4.9 mmol) dropwise. The reaction mixture is stirred at 0 ° C. for 1 hour, at room temperature for 2 hours and under reflux for 4 hours. After completion of the reaction, the solvent was removed in vacuo and column chromatography on silica gel with a mixture of methanol and ethyl acetate (1: 4) afforded the desired compound as a solid (0.55 g).
1H NMR(DMSO-d6) : 2.95(s, 3H), 3.3(s, 3H), 7.1(s, 1H), 10.0(s, 1H). 1 H NMR (DMSO-d 6 ): 2.95 (s, 3H), 3.3 (s, 3H), 7.1 (s, 1H), 10.0 (s, 1H).
MS(70eV) 176(M+).MS (70 eV) 176 (M < + & gt ; ).
상기한 바와 같은 방법으로 메틸히드라진 대신 히드라진, 페닐히드라진을 사용하여 화합물번호 175,177을 제조하였다.Compound No. 175,177 was prepared using hydrazine and phenylhydrazine instead of methylhydrazine in the same manner as described above.
[실시예 4]Example 4
3-히드록시-1-메틸-4-메틸티오피라졸(화합물번호 179):3-hydroxy-1-methyl-4-methylthiopyrazole (Compound No. 179):
에탄올(10ml)중의 1-에톡시카르보닐-1-메틸티오-2-(N, N-디메틸아미노)에텐(1g, 5.3미리몰)을 0℃로 냉각시킨다. 여기에 메틸히드라진(0.3ml, 5.8미리몰)를 적가한다. 반응혼합물을 0℃에서 1시간 상온에서 4시간 환류하에 2시간 교반하였다. 용매를 진공하에서 제거한 후 실리카겔상에서 메탄올과 에틸아세테이트(1:49)의 혼합용액으로 칼럼크로마토그래피한 결과, 피라졸이 하얀 고체(0.6g)로서 얻어졌다.1-ethoxycarbonyl-1-methylthio-2- (N, N-dimethylamino) ethene (1 g, 5.3 mmol) in ethanol (10 ml) is cooled to 0 ° C. To this is added methylhydrazine (0.3 ml, 5.8 mmol) dropwise. The reaction mixture was stirred at 0 ° C. for 1 hour at room temperature under reflux for 4 hours for 2 hours. The solvent was removed in vacuo and column chromatography was performed on silica gel with a mixed solution of methanol and ethyl acetate (1:49) to give pyrazole as a white solid (0.6 g).
1H NMR(CDCl3) : δ2.1(S, 3H), 3.5(s, 3H), 7.3(s, 1H), 10.5(s, 1H). 1 H NMR (CDCl 3 ): δ 2.1 (S, 3H), 3.5 (s, 3H), 7.3 (s, 1H), 10.5 (s, 1H).
MS(70eV) 144(M+).MS (70 eV) 144 (M < + & gt ; ).
상기한 바와 같은 방법으로 메틸히드라진 대신 히드라진, 페닐히드라진을 사용하여 화합물번호 178,180을 제조하였다.Compound number 178,180 was prepared using hydrazine and phenylhydrazine instead of methylhydrazine in the same manner as described above.
[실시예 5]Example 5
3-히드록시-1-메틸-4-에톡시카르보닐피라졸(화합물번호 182) :3-hydroxy-1-methyl-4-ethoxycarbonylpyrazole (Compound No. 182):
1, 1-디에톡시카르보닐-2-(N, N-디메틸아미노)에텐(1g, 4.6미리몰)을 에탄올(10ml)에 넣고, 0℃로 냉각시킨다. 여기에 메틸히드라진(0.27ml, 5.1미리몰)를 적가한다. 반응혼합물을 0℃에서 1시간, 상온에서 3시간, 환류하에 1시간 교반하였다. 반응 종료후, 용매를 진공하에서 제거한 후 에탄올에서 재결정하여 하얀고체(0.65g)를 얻었다.1, 1-diethoxycarbonyl-2- (N, N-dimethylamino) ethene (1 g, 4.6 mmol) is placed in ethanol (10 ml) and cooled to 0 ° C. To this was added methylhydrazine (0.27 ml, 5.1 mmol) dropwise. The reaction mixture was stirred at 0 ° C. for 1 hour, at room temperature for 3 hours, and under reflux for 1 hour. After completion of the reaction, the solvent was removed in vacuo and recrystallized from ethanol to give a white solid (0.65 g).
1H NMR(CDCl3) : δ1.3(t, 3H), 3.65(s, 3H), 4.15(q, 2H), 7.5(s, 1H), 8.5(s, 1H). 1 H NMR (CDCl 3 ): δ 1.3 (t, 3H), 3.65 (s, 3H), 4.15 (q, 2H), 7.5 (s, 1H), 8.5 (s, 1H).
MS(70eV) 170(M+).MS (70 eV) 170 (M + ).
상기한 바와 같은 방법으로 메틸히드라진 대신 히드라진, 페닐히드라진을 사용하여 화합물번호 181,183을 제조하였다.Compound number 181,183 was prepared using hydrazine and phenylhydrazine instead of methylhydrazine in the same manner as described above.
[실시예 6]Example 6
3-히드록시-1-메틸-4-디에틸포스포노피라졸(화합물번호 185):3-hydroxy-1-methyl-4-diethylphosphonopyrazole (Compound No. 185):
1-메톡시카르보닐-1-디에틸포스포노-2-(N, N-디메틸아미노) 에텐(1g, 3.8미리몰)을 에탄올(10ml)에 넣고, 0℃로 냉각시킨다. 여기에 메틸히드라진(0.33g, 3.8미리몰)을 적가한다. 반응혼합물을 0℃에서 1시간, 실온에서 4시간, 환류하에서 2시간 교반한다. 반응 종료후, 진공하에서 용매를 제거한 후 감압증류하면 무색액체의 생성물(0.78g)이 얻어진다.1-methoxycarbonyl-1-diethylphosphono-2- (N, N-dimethylamino) ethene (1 g, 3.8 mmol) is placed in ethanol (10 ml) and cooled to 0 ° C. To this was added methylhydrazine (0.33 g, 3.8 mmol) dropwise. The reaction mixture is stirred at 0 ° C. for 1 hour, at room temperature for 4 hours and under reflux for 2 hours. After the completion of the reaction, the solvent was removed in vacuo and distilled under reduced pressure to yield a colorless liquid (0.78 g).
1H NMR(CDCl3) : 1.3(t, 6H), 3.6(s, 3H), 4.0(q, 4H), 7.3(s, 1H), 9.7(s, 1H). 1 H NMR (CDCl 3 ): 1.3 (t, 6H), 3.6 (s, 3H), 4.0 (q, 4H), 7.3 (s, 1H), 9.7 (s, 1H).
MS(70eV) 234(M+).MS (70 eV) 234 (M < + & gt ; ).
상기한 바와 같은 방법으로 메틸히드라진 대신 히드라진, 페닐히드라진을 사용하여 화합물번호 184,186을 제조하였다.Compound number 184,186 was prepared using hydrazine and phenylhydrazine instead of methylhydrazine in the same manner as described above.
[실시예 7]Example 7
3-히드록시-1-메틸-4-디메틸포스포노파라졸(화합물번호 188):3-hydroxy-1-methyl-4-dimethylphosphonoparasol (Compound No. 188):
1-메톡시카르보닐-1-디메틸포스포노-2-(N, N-디메틸아미노) 에덴(1g, 4.2미리몰)을 에탄올(10ml)에 넣고, 0℃로 냉각시킨다. 여기에 메틸히드라진(0.25ml, 4.6미리몰)을 적가한다. 반응혼합물을 0℃에서 1시간, 실온에서 5시간, 환류하에서 2시간 교반한다. 반응 종료후, 진공하에서 용매를 제거한 후 감압증류하여 무색액체의 생성물(0.56g)을 얻었다.1-methoxycarbonyl-1-dimethylphosphono-2- (N, N-dimethylamino) eden (1 g, 4.2 mmol) is placed in ethanol (10 ml) and cooled to 0 ° C. To this was added methylhydrazine (0.25 ml, 4.6 mmol) dropwise. The reaction mixture is stirred at 0 ° C. for 1 hour, at room temperature for 5 hours and under reflux for 2 hours. After the completion of the reaction, the solvent was removed in vacuo and distilled under reduced pressure to obtain a colorless liquid (0.56 g).
1H NMR(CDCl3) : 3.5(s, 3H), 3.55(s, 3H), 3.7(s, 3H), 7.2(s, 1H), 9.55(s, 1H). 1 H NMR (CDCl 3 ): 3.5 (s, 3H), 3.55 (s, 3H), 3.7 (s, 3H), 7.2 (s, 1H), 9.55 (s, 1H).
MS(70eV) 206(M+).MS (70 eV) 206 (M < + & gt ; ).
상기한 바와 같은 방법으로 메틸히드라진 대신 히드라진, 페닐히드라진을 사용하여 화합물번호 187,189을 제조하였다.Compound number 187,189 was prepared using hydrazine and phenylhydrazine instead of methylhydrazine in the same manner as described above.
[실시예 8]Example 8
0, 0-디에틸-0-(1-메틸-4-페닐설폰일피라졸-3-일)인산 에스테르(화합물번호 10):0, 0-diethyl-0- (1-methyl-4-phenylsulfonylpyrazol-3-yl) phosphate ester (Compound No. 10):
아세토니트릴(10ml)중의 3-히드록시-1-메틸-4-페닐설폰일 피라졸(0.5g, 2.1미리몰), 디에틸클로로포스페이트(0.3ml, 2.1미리몰) 및 탄산칼륨(0.87g)을 실온에서 5시간동안 교반하였다. 반응물을 여과하고, 진공하에서 용매를 제거하여 무색오일(0.55g)이 얻어졌다. 이 오일을 실리카겔상에서 용매로서 헥산과 에틸아세테이트(1:1)의 혼합물로 칼럼크로마토그래피하여 정제시켜 무색오일(0.51g)을 얻었다. 생성물의 핵자기 공명 스펙트럼 결과 이것은 목적하는 화합물번호 10으로 확인되었다.3-hydroxy-1-methyl-4-phenylsulfonyl pyrazole (0.5 g, 2.1 mmol) in acetonitrile (10 ml), diethylchlorophosphate (0.3 ml, 2.1 mmol) and potassium carbonate (0.87 g) Was stirred at room temperature for 5 hours. The reaction was filtered, and the solvent was removed in vacuo to give a colorless oil (0.55 g). This oil was purified by column chromatography on silica gel with a mixture of hexane and ethyl acetate (1: 1) as a solvent to give a colorless oil (0.51 g). Nuclear magnetic resonance spectra of the product showed this was the desired compound number (10).
1H NMR(CDCl3) : 1.35(t, 6H), 3.80(s, 3H), 4.25(q, 4H), 7.30-8.01(m, 6H). 1 H NMR (CDCl 3 ): 1.35 (t, 6H), 3.80 (s, 3H), 4.25 (q, 4H), 7.30-8.01 (m, 6H).
MS(70eV) 374(M+).MS (70 eV) 374 (M < + & gt ; ).
상기한 바와 같은 방법으로 디에틸 클로로포스페이트 대신에 적절한 클로로인산에스테르 메틸하이드라진 대신에 하이드라진 및 페닐 하이드라진을 사용하여 화합물번호 1-24를 제조하였으며, 대표적인 화합물의 MS 및1H NMR은 다음과 같다.Compound No. 1-24 was prepared using hydrazine and phenyl hydrazine instead of appropriate chlorophosphate methylhydrazine in place of diethyl chlorophosphate in the same manner as above. MS and 1 H NMR of the representative compounds are as follows.
화합물번호 9.Compound number 9.
1H NMR(CDCl3) : 3.7(s, 3H), 3.76(s, 3H), 3.95(s, 3H), 7.30-8.00(m, 6H). 1 H NMR (CDCl 3 ): 3.7 (s, 3H), 3.76 (s, 3H), 3.95 (s, 3H), 7.30-8.00 (m, 6H).
MS(70eV) 346(M+).MS (70 eV) 346 (M < + & gt ; ).
화합물번호 14.Compound number 14.
1H NMR(CDCl3) : 1.36(t, 6H), 3.82(s, 3H), 4.30(q, 4H), 7.35-8.01(m, 6H). 1 H NMR (CDCl 3 ): 1.36 (t, 6H), 3.82 (s, 3H), 4.30 (q, 4H), 7.35-8.01 (m, 6H).
MS(70eV) 390(M+).MS (70 eV) 390 (M < + & gt ; ).
[실시예 9]Example 9
0, 0-디에틸-0-(1-메틸-4-페닐티오피라졸-3-일)인산 에스테르0, 0-diethyl-0- (1-methyl-4-phenylthiopyrazol-3-yl) phosphate ester
(화합물번호 34):(Compound No. 34):
아세토니트릴(10ml)중의 3-히드록시-1-메틸-4-페닐티오피라졸(0.5g, 2.4미리몰), 디에틸 클로로포스페이트(0.35ml, 2.4미리몰) 및 탄산칼륨(1.0g, 7.3미리몰)을 실온에서 4시간동안 교반하였다. 이하의 조작은 실시예 8과 같이하여 오일(0.6g)을 얻었다.3-hydroxy-1-methyl-4-phenylthiopyrazole (0.5 g, 2.4 mmol) in acetonitrile (10 ml), diethyl chlorophosphate (0.35 ml, 2.4 mmol) and potassium carbonate (1.0 g, 7.3 Myrimol) was stirred at room temperature for 4 hours. The following operations were carried out in the same manner as in Example 8 to obtain oil (0.6 g).
1H NMR(CDCl3) : 1.35(t, 6H), 3.70(s, 3H), 4.20(q, 4H), 7.1-7.60(m, 6H). 1 H NMR (CDCl 3 ): 1.35 (t, 6H), 3.70 (s, 3H), 4.20 (q, 4H), 7.1-7.60 (m, 6H).
MS(70eV) 342(M+).MS (70 eV) 342 (M < + & gt ; ).
상기한 바와 같은 방법으로 디에틸클로로포스페이트 대신에 적절한 클로로인산 에스테르를 사용하여 화합물번호 25-48을 제조하였다.Compounds 25-48 were prepared using the appropriate chlorophosphate esters in place of diethylchlorophosphate in the same manner as described above.
[실시예 10]Example 10
0, 0-디에틸-0-(1-메틸-4-메틸설폰일피라졸-3-일)인산에스테르(화합물번호58):0, 0-diethyl-0- (1-methyl-4-methylsulfonylpyrazol-3-yl) phosphate ester (Compound No. 58):
염화메틸렌(5ml)중의 3-히드록-1-메틸-4-메틸설폰일피라졸(0.5g, 2.8미리몰), 디에틸클로로포스페이트(0.41ml, 2.8미리몰) 및 트리에틸아민(0.40ml, 2.8미리몰)를 실온에서 5시간동안 교반하였다. 반응종료후, 반응물을 여과하고, 용매는 진공하에서 제거하고, 잔류물을 실리카겔상에서 용매로서 헥산과 에틸아세테이트(1:1)의 혼합물을 사용하여, 칼럼크로마토그래피하여 정제시켜 오일(0.74g)을 얻었다.3-hydroxy-1-methyl-4-methylsulfonylpyrazole (0.5 g, 2.8 mmol), diethylchlorophosphate (0.41 ml, 2.8 mmol) and triethylamine (0.40 ml) in methylene chloride (5 ml) , 2.8 mmol) was stirred at room temperature for 5 hours. After completion of the reaction, the reaction was filtered, the solvent was removed in vacuo, and the residue was purified by column chromatography on silica gel using a mixture of hexane and ethyl acetate (1: 1) as a solvent to give an oil (0.74 g). Got it.
1H NMR(CDCl3) : δ1.35(t, 6H), 2.95(s, 3H), 3.35(s, 3H), 4.20(q, 4H), 7.1(s, 1H). 1 H NMR (CDCl 3 ): δ 1.35 (t, 6H), 2.95 (s, 3H), 3.35 (s, 3H), 4.20 (q, 4H), 7.1 (s, 1H).
MS(70eV) 312(M+).MS (70 eV) 312 (M < + & gt ; ).
상기한 바와 같은 방법으로, 디에틸 클로로포스페이트 대신에 적절한 클로로인산 에스테르를 사용하여 화합물번호 49-72를 제조하였다.In the same manner as described above, compounds Nos. 49-72 were prepared using the appropriate chlorophosphate esters in place of diethyl chlorophosphate.
[실시예 11]Example 11
0, 0-디에틸-0-(1-메틸-4-메틸티오피라졸-3-일)티오인산에스테르(화합물번호 86).0, 0-diethyl-0- (1-methyl-4-methylthiopyrazol-3-yl) thiophosphate ester (Compound No. 86).
염화메틸렌(5ml)중의 3-히드록시-1-메틸-4-메틸티오피라졸(0.5g, 3.5미리몰), 디에틸 클로로티오포스페이트(0.55ml, 3.5미리몰) 및 트리에틸아민(0.48ml, 1.35미리몰)을 상온에서 4시간 교반하였다. 이하의 조작은 실시예 10과 같이하여 무색의 오일(0.87g)을 얻었다.3-hydroxy-1-methyl-4-methylthiopyrazole (0.5 g, 3.5 mmol) in methylene chloride (5 ml), diethyl chlorothiophosphate (0.55 ml, 3.5 mmol) and triethylamine (0.48 ml , 1.35 mmol) was stirred at room temperature for 4 hours. The following operations were carried out in the same manner as in Example 10, to obtain a colorless oil (0.87 g).
1H NMR(CDCl3) : δ1.37(t, 6H), 2.30(s, 3H), 3.62(s, 3H), 4.28(q, 4H), 7.82(s, 1H). 1 H NMR (CDCl 3 ): δ 1.37 (t, 6H), 2.30 (s, 3H), 3.62 (s, 3H), 4.28 (q, 4H), 7.82 (s, 1H).
MS(70eV) 296(M+).MS (70 eV) 296 (M < + & gt ; ).
상기한 바와 같은 방법으로, 디에틸 클로로티오포스페이트 대신에 적절한 클로로인산에스테르를 사용하여 화합물번호 73-96를 제조하였으며, 대표적인 화합물의 NMR 및 MS는 다음과 같다.In the same manner as described above, compounds Nos. 73-96 were prepared using appropriate chlorophosphate esters instead of diethyl chlorothiophosphate, and NMR and MS of the representative compounds are as follows.
화합물번호 82.Compound number 82.
1H NMR(CDCl3) : δ1.35(t, 6H), 2.25(s, 3H), 3.7(s, 3H), 4.25(q, 4H), 7.25(s, 1H). 1 H NMR (CDCl 3 ): δ 1.35 (t, 6H), 2.25 (s, 3H), 3.7 (s, 3H), 4.25 (q, 4H), 7.25 (s, 1H).
MS(70eV) 280(M+).MS (70 eV) 280 (M + ).
화합물번호 85.Compound number 85.
1H NMR(CDCl3) : δ2.25(s, 3H), 3.7(s, 3H), 3.8(s, 3H), 4.0(s, 3H), 7.35(s, 1H). 1 H NMR (CDCl 3 ): δ 2.25 (s, 3H), 3.7 (s, 3H), 3.8 (s, 3H), 4.0 (s, 3H), 7.35 (s, 1H).
MS(70eV) 268(M+).MS (70 eV) 268 (M < + & gt ; ).
[실시예 12]Example 12
0, 0-디에틸-0-(1-메틸-4-에톡시카르보닐피라졸-3-일)인산에스테르(화합물번호 106).0, 0-diethyl-0- (1-methyl-4-ethoxycarbonylpyrazol-3-yl) phosphate ester (Compound No. 106).
염화메틸렌(5ml)중의 3-히드록시-1-메틸-4-에톡시카르보닐피라졸(0.5g, 2.9미리몰), 디에틸클로로포스페이트(0.43ml, 2.9미리몰) 및 트리에틸아민(0.41ml, 2.9미리몰)를 상온에서 5시간 교반하였다. 이하의 조작은 실시예 10과 같이하여 무색의 오일(0.8g)이 얻어졌다.3-hydroxy-1-methyl-4-ethoxycarbonylpyrazole (0.5 g, 2.9 mmol) in methylene chloride (5 ml), diethylchlorophosphate (0.43 ml, 2.9 mmol) and triethylamine (0.41 ml, 2.9 mmol) was stirred at room temperature for 5 hours. The following operation was performed like Example 10 and the colorless oil (0.8g) was obtained.
1H NMR(CDCl3) : δ1.40(t, 9H), 3.75(s, 3H), 4.2(q, 6H), 7.6(s, 1H). 1 H NMR (CDCl 3 ): δ 1.40 (t, 9H), 3.75 (s, 3H), 4.2 (q, 6H), 7.6 (s, 1H).
MS(70eV) 306(M+).MS (70 eV) 306 (M < + & gt ; ).
상기한 바와 같은 방법으로, 디에틸클로로포스페이트 대신에 적절한 클로로인산에스테르를 사용하여 화합물번호 97-120을 제조하였으며, 대표적인 화합물의 NMR 및 MS는 다음과 같다.In the same manner as described above, compounds No. 97-120 were prepared using appropriate chlorophosphate esters instead of diethylchlorophosphate, and NMR and MS of the representative compounds are as follows.
화합물번호 110:Compound number 110:
1H NMR(CDCl3) : δ1.30(t, 9H), 3.75(s, 3H), 4.10(m, 6H), 7.40(s, 1H). 1 H NMR (CDCl 3 ): δ 1.30 (t, 9H), 3.75 (s, 3H), 4.10 (m, 6H), 7.40 (s, 1H).
MS(70eV) 322(M+).MS (70 eV) 322 (M < + & gt ; ).
[실시예 13]Example 13
0, 0-디에틸-0-(1-메틸-4-디에틸포스포노피라졸-3-일)티오인산 에스테르(화합물번호 134).0, 0-diethyl-0- (1-methyl-4-diethylphosphonopyrazol-3-yl) thiophosphate ester (Compound No. 134).
염화메틸렌(5ml)중의 3-히드록시-1-메틸-4-디에틸포스포노피라졸(0.5g, 2.1미리몰), 디에틸클로로티오포스페이트(0.34ml, 2.1미리몰) 및 트리에틸아민(0.30ml, 2.1미리몰)을 상온에서 7시간 교반하였다. 이하의 조작은 실시예 10과 같이하여 무색의 오일(0.67g)이 얻었다.3-hydroxy-1-methyl-4-diethylphosphonopyrazole (0.5 g, 2.1 mmol) in methylene chloride (5 ml), diethylchlorothiophosphate (0.34 ml, 2.1 mmol) and triethylamine ( 0.30 ml, 2.1 mmol) was stirred at room temperature for 7 hours. The following operation was performed like Example 10 and the colorless oil (0.67g) was obtained.
1H NMR(CDCl3) : 1.3(m, 12H), 3.7(s, 3H), 4.0(m, 8H), 7.3(s, 1H). 1 H NMR (CDCl 3 ): 1.3 (m, 12H), 3.7 (s, 3H), 4.0 (m, 8H), 7.3 (s, 1H).
MS(70eV) 386(M+).MS (70 eV) 386 (M < + & gt ; ).
상기한 바와 같은 방법으로, 디에틸클로로 티오포스페이트대신에 적절한 클로로인산 에스테르를 사용하여 화합물번호 121-144를 제조하였으며, 대표적인 화합물의 NMR 및 MS는 다음과 같다. 화합물번호 122.In the same manner as described above, compounds Nos. 121-144 were prepared using chlorophosphate esters instead of diethylchloro thiophosphate, and NMR and MS of the representative compounds are as follows. Compound number 122.
1H NMR(CDCl3) : δ1.3(m, 12H), 4.0(m, 8H), 7.6(s, 1H), 12.0(s, 1H). 1 H NMR (CDCl 3 ): δ 1.3 (m, 12H), 4.0 (m, 8H), 7.6 (s, 1H), 12.0 (s, 1H).
MS(70eV) 356(M+).MS (70 eV) 356 (M < + & gt ; ).
화합물번호 129.Compound number 129.
1H NMR(CDCl3) : δ1.3(t, 6H), 3.5(d, 6H), 3.9(s, 3H), 4.0(q, 4H), 7.3(s, 1H). 1 H NMR (CDCl 3 ): δ 1.3 (t, 6H), 3.5 (d, 6H), 3.9 (s, 3H), 4.0 (q, 4H), 7.3 (s, 1H).
MS(70eV) 342(M+).MS (70 eV) 342 (M < + & gt ; ).
화합물번호 130.Compound number 130.
1H NMR(CDCl3) : δ1.3(m, 12H), 4.1(m, 11H), 7.3(s, 1H). 1 H NMR (CDCl 3 ): δ 1.3 (m, 12H), 4.1 (m, 11H), 7.3 (s, 1H).
MS(70eV) 370(M+).MS (70 eV) 370 (M < + & gt ; ).
[실시예 14]Example 14
0, 0-디에틸-0-(1-메틸-4-디메틸포스포노피라졸-3-일)인산 에스테르(화합물번호 154):0, 0-diethyl-0- (1-methyl-4-dimethylphosphonopyrazol-3-yl) phosphate ester (Compound No. 154):
염화메틸렌(5ml)중의 3-히드록시-1-메틸-4-디메틸포스포노피라졸(0.5g, 2.4미리몰), 디에틸클로로포스페이트(0.35ml, 2.4미리몰) 및 트리에틸아민(0.34ml, 2.4미리몰)을 상온에서 6시간동안 교반하였다. 이하의 조작은 실시예 10과 같이하여 오일(0.66g)이 얻어졌다.3-hydroxy-1-methyl-4-dimethylphosphonopyrazole (0.5 g, 2.4 mmol) in methylene chloride (5 ml), diethylchlorophosphate (0.35 ml, 2.4 mmol) and triethylamine (0.34 ml) , 2.4 mmol) was stirred at room temperature for 6 hours. The following operation was carried out similarly to Example 10, and oil (0.66g) was obtained.
1H NMR(CDCl3) : δ1.4(t, 6H), 3.6(s, 3H), 3.8(s, 6H), 4.2(q, 4H), 7.3(s, 1H). 1 H NMR (CDCl 3 ): δ 1.4 (t, 6H), 3.6 (s, 3H), 3.8 (s, 6H), 4.2 (q, 4H), 7.3 (s, 1H).
MS(70eV) 342(M+).MS (70 eV) 342 (M < + & gt ; ).
상기한 바와 같은 방법으로, 디에틸 클로로포스페이트 대신에 적절한 클로로인산 에스테르를 사용하여 화합물번호 145-168을 제조하였다.In the same manner as described above, compound Nos. 145-168 were prepared using an appropriate chlorophosphate ester in place of diethyl chlorophosphate.
[실험예 1]Experimental Example 1
본 발명의 방법에 따라 제조된 대표적인 피라졸 화합물은 살충 및 살비활성의 측면에서 다음의 시험방법에 의해 평가된다. 시험 약액의 조제는 시험화합물 50밀리그람을 아세톤 5밀리리터에 완전 용해시킨 후 계면활성제인 트리톤 엑스-100 100ppm 수용액 45밀리리터와 혼합하여 1000ppm 농도의 공시 약액으로 한다. 시험과정은 다음과 같다.Representative pyrazole compounds prepared according to the methods of the invention are evaluated by the following test methods in terms of pesticidal and acaricidal activity. To prepare the test chemicals, 50 milligrams of the test compound is completely dissolved in 5 milliliters of acetone, and then mixed with 45 milliliters of a Triton X-100 100 ppm aqueous solution, which is a surfactant, to prepare a test solution having a concentration of 1000 ppm. The test process is as follows.
가. 벼멸구(Brown planthopper)end. Brown planthopper
상기 해충(BPH)(Nilaparvata lugens stal)은 실내에서 살충제 도태없이 누대 사육된 감수성 계통을 아크릴 케이지(가로 26cm, 세로 29cm, 높이 20cm)당 최종 성충밀도가 약 500마리가 되도록 일정 연령의 유충을 항온실(온도 27±1℃), 상대습도 50±5%, 광조건 16명 8암)에서 동진벼를 이용하여 실내 사육한다. 살충 시험에는 우화후 4일째의 암컷 성충을 공시한다.The pest (BPH) (Nilaparvata lugens stal) is a sensitized strain that was raised indoors without insecticides, and the larvae of a certain age so that the final adult density per acrylic cage (26 cm, 29 cm, 20 cm in height) is approximately 500 Breeding indoors using Dongjin rice in a greenhouse (temperature 27 ± 1 ℃), relative humidity 50 ± 5%, light conditions 16 persons 8 cancer). Insecticidal testing reveals adult females 4 days after fable.
초장 5-7cm의 수도 유묘(품종;동진) 6본을 탈지면으로 말아 시험관(직경 3cm, 높이 15cm)에 삽입한 후 상기 성충을 20마리 접종한다. 시험관의 입구 중앙부에 미량 분무기(1회 분사량 0.0254±0.0005ml)의 노즐을 위치시켜, 상기 1000ppm 현탄액을 2회 분사한다. 대조구는 시험 약제를 함유하지 않은 아세톤-계면활성제-중류수 용액을 처리한다. 각각의 처리는 3반복으로 실시한다. 처리후 항온실(온도 25±1℃, 상대습도 50±5%, 광조건 16명 8암)에 보관하면서 24시간, 48시간후에 사충율을 조사한다. 침으로 자극을 주었을 때 반사 작용을 보이지 않는 것은 사망 개체로 판정한다.Six seedlings (breed; Dongjin), 5-7 cm tall, are rolled with cotton wool, inserted into a test tube (3 cm in diameter, 15 cm in height), and 20 adult insects are inoculated. A nozzle of a micro atomizer (a single injection amount of 0.0254 ± 0.0005 ml) is placed at the center of the inlet of the test tube, and the 1000 ppm suspension liquid is sprayed twice. The control treated with acetone-surfactant-heavy water solution containing no test agent. Each treatment is carried out in three repetitions. After treatment, the mortality rate was examined after 24 hours and 48 hours while being kept in a constant temperature room (temperature 25 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people 8 cancer). Those who did not show reflexes when stimulated with saliva are considered dead individuals.
나. 복숭아 혹진딧물(Green Peach aphid)I. Green Peach aphid
상기 해충(GPA)(Myzus persicae sulzer)은 실내에서 2년간 살충제 도태없이 수대 사육된 계통으로서 항온실(온도 21±1℃, 상대습도 50±5%, 광조건 16명 8암)에서 담배(품종; NC-82)를 이용하여 실내 사육한다. 살충 시험에는 무시 자층을 공시한다.The insect pest (GPA) (Myzus persicae sulzer) is a breeding system without insecticides for 2 years indoors in a constant temperature room (temperature 21 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people 8 cancers); Indoor breeding using NC-82). Insecticide tests are to be published with neglected class.
시험 화합물은 상기 약액의 조제법에서 기술한 바와 같은 1000ppm 시험약액 50밀리리터에 직경 9cm의 완형으로 자른 담배잎(품종; NC-82)을 30초간 침적시킨 후 30분간 통건시키고 나서 9cm 페트리 접시에 둔다. 대조구는 아세톤-계면활성제-증류수 용액에 침적 처리한다. 각각의 처리는 3반복으로 실시한다. 무시자충 20마리를 각각의 처리된 담배잎에 접종한 후 황온실(온도 25±1℃, 상대습도 50±5%, 광조건 16명, 8암)에 보관하면서 24시간, 48시간 후에 사충율을 조사한다. 가는 붓끝으로 자극을 주었을 때 반사 작용을 보이지 않는 것은 사망 개체로 간주한다.The test compound was immersed in 50 milliliters of the 1000 ppm test solution as described in the preparation of the above-mentioned chemical solution (variety; NC-82) cut into a 9 cm diameter toy for 30 seconds, then passed through for 30 minutes, and placed in a 9 cm Petri dish. The control was immersed in acetone-surfactant-distilled water solution. Each treatment is carried out in three repetitions. 20 insects were inoculated into each treated tobacco leaf and stored in yellow-green room (temperature 25 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people, 8 cancers). Investigate. Those who do not show reflexes when stimulated with a thin brush tip are considered dead.
다. 콩 진딧물(Soybean aphid)All. Soybean aphid
상기 해충(SA)(Aphis glycines matsumura)은 실내에서 2년간 살충제 도태없이 누대 사육된 계통으로서, 항온실(온도 21±1℃, 상대습도 50±5%, 광조건 16명, 8암)에서 콩을 기주식물로 하여 실내 사육한다. 살충 시험에는 무시자충을 공시한다.The pest (SA) (Aphis glycines matsumura) is a system that was raised in a room without insecticides for two years in the room, soybeans in a constant temperature room (temperature 21 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people, 8 cancers) Breed indoors as host plants. Insecticidal tests are also disclosed with nymphs.
시험화합물은 상기 약제 조제법에서 기술한 바와 같은 1000ppm 시험 약액 50밀리리터에 잎이 2본 달려 있는 콩줄기를 30초간 침적처리한 후 30분간 풍건시키고 나서 폴리스틸렌(직경 6cm, 높이 7.5cm)에 고정시킨다. 대조구는 아세톤-계면활성-증류수 용액에 침적 처리한다. 각각의 처리는 3반복으로 실시한다. 무시자충 20마리를 각각의 처리된 콩잎에 접종한 후 항온실(온도 25±1℃, 상대습도 50±5%, 광조건 16명, 8암)에 보관하면서 24시간, 48시간후에 사충율을 조사한다. 가는 붓끝으로 자극을 주었을 때 반사작용을 보이지 않는 것은 사망 개체로 한다.The test compound was soaked in 50 milliliters of the 1000 ppm test chemical solution as described in the above-mentioned pharmaceutical preparation method for 30 seconds, and then air-dried for 30 seconds, and then fixed in polystyrene (6 cm in diameter and 7.5 cm in height). The control was deposited in acetone-surfactant-distilled water solution. Each treatment is carried out in three repetitions. 20 insects were inoculated into each treated soybean leaf and stored in a constant temperature room (temperature 25 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people, 8 cancers) and examined for mortality after 24 hours and 48 hours. do. When irritated with a thin brush tip, it does not show reflex action.
라. 배추좀나방(diamond-back moth)la. Diamond-back moth
상기 해충(DBH)(Plutella xylostella linnaeus)은 (온도 27±1℃, 상대습도 50±5%, 광조건 16명, 8암)에서 배추를 이용하여 살충제 도태없이 누대 사육했다. 사육 상자당 평균 밀도는 500마리 정도로 하며, 살충 시험에는 3명 유충을 공시한다.The insect pest (DBH) (Plutella xylostella linnaeus) was bred using the cabbage at the temperature (27 ± 1 ℃, relative humidity 50 ± 5%, 16 light conditions, 8 cancers) without any pesticide selection. The average density per breeding box is around 500, and three larvae should be published for pesticide testing.
배추잎을 직경 9cm의 원형으로 잘라 1000ppm 시험 약액에 30초간 침적시킨후 30분간 풍건시킨다. 대조구는 시험 화합물을 포함하지 않은 아세톤-계면활성제-증류수 용액을 처리한다. 처리된 잎을 직경 9cm 페트리 접시에 넣고 3명 유충 10마리를 접종한다. 각각의 처리는 3반복으로 하는데 페트리 접시는 뚜껑을 덮어 항온심(온도 25±1℃, 상대습도 50±5%, 광조건 16명 8암)에 보관하면서 24시간, 48시간후에 사충율을 조사한다. 가는 붓끝으로 건드렸을 때 반사작용을 보이지 않는 것은 사망한 것으로 판정한다.Cut the cabbage leaves into 9cm diameter circles, soak them in 1000ppm test chemicals for 30 seconds and air dry for 30 minutes. The control treated with acetone-surfactant-distilled water solution that did not contain the test compound. The treated leaves are placed in a 9 cm diameter Petri dish and inoculated with 10 3 larvae. Each treatment is repeated three times. Petri dishes are covered with a lid and kept at a constant temperature (temperature 25 ± 1 ℃, relative humidity 50 ± 5%, light conditions of 16 people, 8 cancers) and examined for mortality after 24 hours and 48 hours. . Anything that does not show reflexes when touched with a thin brush tip is considered dead.
마. 허리노린재(Bean Bug)hemp. Bean Bug
상기 해충(Riptortus Clartitus Thunberg)을 야외에서 채집하여, 항온실(온도 25±1℃, 상대습도 50±5%, 광조건 16명 8암)내에서 1년이상 살충제 도태없이 누대 사육한 것을 공사층으로 사용한다. 살충시험은 수분을 함유한 버미큐라이트 배제에서 발아시킨 대두 유묘(파종후 5-7일 묘, 뿌리 4-5cm) 3분을 약액에 30초동안 침적시킨 후 풍진시킨다음 ø6×3.5cm의 투명 폴리에틸렌 용기에 넣고 노린 재 3령 약층 10마리를 접종한다. 한편 대조군에 대해서는 공시 약물이 포함되어 있지 않는 아세톤-계면활성제-증류수 용액으로 처리한다. 시험군 및 대조군에 대하여 각각 3회 반복 처리한 후, 용기의 뚜껑을 덮어 항온실(온도 25°±1℃, 상대습도 50±5%, 광조건 16명 8암)에 보관하면서 24시간, 48시간후에 사망률을 조사한다. 가는 침으로 자극을 주었을 때 반사작용이 없는 것은 사망개체로 한다.The pests (Riptortus Clartitus Thunberg) were collected outdoors, and cultivated with no pesticides in a constant temperature room (temperature 25 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people 8 cancer) for more than 1 year to the construction layer. use. Insecticidal test was carried out by immersing 3 minutes of soybean seedlings (5-7 days after sowing, roots 4-5cm) germinated in the exclusion of water-containing vermiculite for 30 seconds and rubella, and then ø6 × 3.5cm transparent Place in a polyethylene container and inoculate 10 layers of 3rd material. On the other hand, the control group is treated with acetone-surfactant-distilled water solution that does not contain the disclosed drug. Repeated treatment three times for the test group and the control group, and then covered with a lid of the container 24 hours, 48 hours while storing in a constant temperature room (temperature 25 ° ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people 8 cancer) Examine mortality later. When irritated with fine needles, no reflexes are caused by death.
바. 점박이응애(Two-spotted spider mite)bar. Two-spotted spider mite
상기 해충(TSSM)(Tetranychus urticae koch)은 살충제 감수성 계통을 항온실(온도 23±1℃, 상대습도 50±5%, 광조건 16명 8암)에서 강남콩잎을 이용하여 실내 사육한다. 살충 시험에는 성충을 공시한다.The insect pest (TSSM) (Tetranychus urticae koch) is a breeding indoors using gangnambean leaves in a pesticide-sensitive system in a constant temperature room (temperature 23 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people 8 cancer). Insecticide tests reveal the adult.
한천액(한천 함량 0.5%)을 사례에 깊이 1cm 정도가 되게 흘려 넣고 그위에 강남콩 잎을 고정시키고 성충을 40마리 접종한 후, 미량 분무기를 이용하여 1000ppm 시험 약액 3밀리리터를 살포한다. 대조구는 시험 화합물을 포함하지 않는 아세톤-계면활성제-증류수 용액을 살포한다. 각각의 처리는 3반복으로 한다. 처리후 항온실(온도 25±1℃, 상대습도 50±5%, 광조건 16명, 8암)에 보관하면서 24시간, 48시간후에 현미경 관찰을 통하여 사충율을 조사한다. 자극을 줄 때 움직이는 것은 살아 있는 것으로 간주한다.Agar solution (0.5% agar content) is poured into the case to a depth of about 1cm, the Gangnam bean leaves are fixed on it, 40 adult seeds are inoculated, and 3 milliliters of the 1000 ppm test chemical solution is sprayed using a micro sprayer. The control is sparged with an acetone-surfactant-distilled water solution that does not contain the test compound. Each treatment is repeated three times. After treatment, the mortality rate was examined by microscopic observation 24 hours and 48 hours in a constant temperature room (temperature 25 ± 1 ℃, relative humidity 50 ± 5%, light conditions 16 people, 8 cancers). Moving when stimulating is considered alive.
상기한 방법에 의해 얻어진 시험결과는 사망률로 표 3에 표시하였으며 사망율은 다음식에 의하여 산출하였다.The test results obtained by the above method are shown in Table 3 as the mortality rate and the mortality rate was calculated by the following equation.
[표 3]TABLE 3
상기 표 1에서 알 수 있는 바와 같이, 본 발명의 신규 화합물은 특허공고 제84-255에 수재된 화합물에 비하여 탁월한 생리활성을 가진다.As can be seen in Table 1, the novel compounds of the present invention have excellent physiological activity compared to the compounds listed in Patent Publication No. 84-255.
본 발명의 화합물(1)은 살충제로서 유효하다.Compound (1) of the present invention is effective as an insecticide.
본 발명의 화합물은 1종 또는 2종 이상의 혼합물을 적당한 담체 및/또는 희석제와 혼합하여 적당한 형태, 예를 들면, 유제, 수화제, 분제, 입제 등으로 투여할 수 있다.The compounds of the present invention may be administered in one or two or more mixtures in a suitable form, such as emulsions, wetting agents, powders, granules, etc., by mixing with a suitable carrier and / or diluent.
본 발명의 유효성분의 함유비율은 그 사용목적에 따라서 상이하다.The content rate of the active ingredient of this invention differs according to the purpose of use.
예를 들면, 유제, 수화제등은 10-90%(중량)이 바람직하며, 분제등은 0.1-10%(중량)이 바람직하나, 이량의 변경은 사용 목적에 따라서 가능하다.For example, an emulsion, a hydrating agent, etc. is preferable 10-90% (weight), and powder, etc., 0.1-10% (weight) is preferable, but a change of this quantity is possible according to a use purpose.
본 발명의 조성물에 사용하는 담체로서는 액체 담체로서 물, 알콜류(메탄올과 같은 1가알콜, 에틸렌글리콜 같은 2가알콜 및 글리세린 등과 같은 3가알콜 등), 캐톤류(아세톤, 메틸에틸케톤 등), 에테르류(디옥산, 테트라하이드로후란, 셀로솔브 등), 지방족 탄화수소류(가솔린, 케로센, 등유 등), 방향족 탄화수소류(벤젠, 톨루엔, 키실렌, 솔벤트, 나프타 등), 할로겐화탄화수소류(클로로포름, 4염화탄소 등), 산아미이드류(디메틸포름아마이드 등), 에스테르류(초산에틸, 초산부틸, 지방산글리세린에스테르 등), 니트릴류(아세토니트릴 등)등이 있으며, 이들은 단독 또는 2종이상의 혼합물로 사용할 수 있다.Examples of the carrier for use in the composition of the present invention include liquids such as water, alcohols (monohydric alcohols such as methanol, dihydric alcohols such as ethylene glycol and trihydric alcohols such as glycerin), cantons (acetone, methyl ethyl ketone, etc.), Ethers (dioxane, tetrahydrofuran, cellosolve, etc.), aliphatic hydrocarbons (gasoline, kerosene, kerosene, etc.), aromatic hydrocarbons (benzene, toluene, xylene, solvent, naphtha, etc.), halogenated hydrocarbons ( Chloroform, carbon tetrachloride, etc.), acid amides (dimethylformamide, etc.), esters (ethyl acetate, butyl acetate, fatty acid glycerin esters, etc.), and nitriles (acetonitrile, etc.), and these may be used alone or in combination. It can be used as a mixture.
고체 담체로서는 광물성입자(카올린, 점토, 벤토나이트, 산성백토, 활석, 규조토, 실리카, 모래 등), 식물성분말(목분 등), 기타의 광물질 입자를 사용할 수 있다.As the solid carrier, mineral particles (kaolin, clay, bentonite, acid clay, talc, diatomaceous earth, silica, sand, etc.), plant powder (wood powder, etc.), and other mineral particles can be used.
본 발명의 조성물에는 유화제, 전착제, 분산제, 참윤제 등을 사용할 수 있다. 예를 들면 지방산소다, 폴리옥시알킬에스테르류, 알킬설포네이트류, 폴리에틸렌글리콜에테르류, 등과 같은 비이온성, 음이온성 또는 양이온성 계면활성제를 사용할 수 있다.An emulsifier, an electrodeposition agent, a dispersing agent, a true lubricant etc. can be used for the composition of this invention. For example, nonionic, anionic or cationic surfactants such as fatty acid soda, polyoxyalkyl esters, alkylsulfonates, polyethylene glycol ethers, and the like can be used.
본 발명의 조성물은 또한 다른 종류의 농화학적으로 활성인 성분, 예를 들면, 상충제, 제초제, 식물호르몬제, 살균제 등을 혼합하여 사용할 수도 있다.The composition of the present invention may also be used in combination with other kinds of agrochemically active ingredients, such as conflicting agents, herbicides, plant hormones, fungicides and the like.
또한 본 발명의 조성물은 비료 등을 혼합하여 사용할 수도 있다(다음 조성예에서 %는 모두 중량%이다).In addition, the composition of the present invention may be used by mixing a fertilizer or the like (% in the following composition examples are all weight%).
조성물 예 1(유제)Composition Example 1 (Emulsion)
화합물번호 170 20%Compound number 170 20%
키실렌 75%Xylene 75%
폴리옥시에틸렌글리콜에테르 5%Polyoxyethylene glycol ether 5%
상기 성분을 혼합하여 유제를 제조하였다.The above ingredients were mixed to prepare an emulsion.
조성물 예 2(분제)Composition Example 2 (Powder)
화합물번호 180 5%Compound number 180 5%
카올린 94.6%Kaolin 94.6%
실리콘(소포제) 0.3%Silicone (defoamer) 0.3%
폴리에틸렌글리콜에테르 0.1%Polyethylene glycol ether 0.1%
상기 성분을 혼합하여 분제를 제조하였다.The powder was prepared by mixing the above components.
조성물 예 3(수화제)Composition Example 3 (Hydrating)
화합물번호 188 30%Compound number 188 30%
리그닌설포산 소다 5%Lignin sulfoic acid soda 5%
폴리옥시에틸렌글리콜에테르 5%Polyoxyethylene glycol ether 5%
벤토나이트 60%Bentonite 60%
상기 성분을 혼합하여 수화제를 제조하였다.The above ingredients were mixed to prepare a hydrating agent.
조성물 예 4(입제)Composition Example 4 (granular)
화합물번호 176 10%Compound number 176 10%
리그닌설폰산 소다 5%Lignin sulfonic acid soda 5%
벤토나이트 85%Bentonite 85%
상기 성분에 물을 가하여 반죽한 후 입화하여 입제를 제조하였다.Water was added to the ingredients to knead and then granulated to prepare granules.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870011155A KR900002055B1 (en) | 1987-10-06 | 1987-10-06 | Pyrazole derivatives having pysiological activity and the preparing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870011155A KR900002055B1 (en) | 1987-10-06 | 1987-10-06 | Pyrazole derivatives having pysiological activity and the preparing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890006592A KR890006592A (en) | 1989-06-14 |
KR900002055B1 true KR900002055B1 (en) | 1990-03-31 |
Family
ID=19265037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870011155A KR900002055B1 (en) | 1987-10-06 | 1987-10-06 | Pyrazole derivatives having pysiological activity and the preparing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR900002055B1 (en) |
-
1987
- 1987-10-06 KR KR1019870011155A patent/KR900002055B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR890006592A (en) | 1989-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900003088B1 (en) | 5-hydroxy prazole derivatives | |
KR20010006084A (en) | Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient | |
KR900002055B1 (en) | Pyrazole derivatives having pysiological activity and the preparing method thereof | |
US4303653A (en) | Organic phosphoric acid ester derivatives, a process for preparing the same and insecticidal, miticidal or nematocidal compositions containing the same | |
KR900002057B1 (en) | 5-hydroxa pyrazole derivatives having pysiological active property | |
US4209512A (en) | Mono- and di-thiophosphate esters containing an isoxazolinone ring and compositions and methods containing the same | |
KR900002060B1 (en) | Pyrimidines having physiological activity and the preparation process thereof | |
KR900002056B1 (en) | New 3-hydroxy pyrazole derivatives | |
CA1058630A (en) | O, s-dialkyl o-sulfonyloxyphenyl phosphorothiolates and phosphorodithioates | |
US4112083A (en) | Pesticidal O,S-dialkyl O-sulfonyloxyphenyl phosphorothiolates and phosphorodithioates | |
JP2714671B2 (en) | Thiadiazabicyclononane derivatives and herbicides | |
US3904639A (en) | Thiazolotriazolyphosphonothioates | |
KR920001991B1 (en) | Process for the preparation of organophosphorus compounds having pesticidalactivity | |
KR940007420B1 (en) | Pyrazole phosphoric acid ester derivative | |
US4024252A (en) | 2-(5-Ethyl-6-bromothiazolo[3,2-b]-5-triazolyl)thiophosphonate esters, compositions and method of use | |
EP0054589A1 (en) | Organic phosphoric acid ester derivatives, a process for preparing the same and insecticidal, miticidal or nematocidal compositions containing the same | |
KR800001635B1 (en) | Preparing process for organic phosphorus estens | |
US4053499A (en) | O,s-dialkyl o-sulfonyloxyphenyl phosphorothiolates and phosphorodithioates | |
KR860000853B1 (en) | Process for the preparation of pyrazol phosphates | |
KR910007886B1 (en) | Method for production of pyrazol sulfonate derivatives | |
KR950009521B1 (en) | Pesticidal compositions | |
JP4180377B2 (en) | Pest control agent | |
KR830002893B1 (en) | Process for preparation of pyridazone derivatives | |
KR940002710B1 (en) | Novel pyrethroid compounds containing isoxazole moieties | |
JP2700743B2 (en) | Organophosphorus compound, process for producing the same, and insecticide, acaricide and nematicide containing the compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19980204 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |